Identification of Novel and Improved Antimitotic Agents Derived from Noscapine

Identification of Novel and Improved Antimitotic Agents Derived from Noscapine Discovery of S-Phase Arresting Agents Derived from Noscapine Anticancer Potential of N‐Sulfonyl Noscapinoids: Synthesis and Evaluation Rational design of novel N‐alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents Novel 9′-substituted-noscapines: Synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents Induction of acetylation and bundling of cellular microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest in MDA-MB-231 cells Tubulin Binding, Protein-Bound Conformation in Solution, and Antimitotic Cellular Profiling of Noscapine and Its Derivatives <scp>9‐Ethynyl</scp> noscapine induces <scp>G2</scp> /M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer Synthesis and Pharmacological Evaluation of N-(3-(1H-Indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a Potent Antimitotic Agent